| Bioactivity | Dasatinib intermediate-1 is an intermediate in the synthesis of Dasatinib (HY-10181). Dasatinib Is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity[1]. |
| CAS | 302964-08-5 |
| Formula | C16H13Cl2N5OS |
| Molar Mass | 394.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Distler JH, et al. Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v10-1. |
Dasatinib intermediate-1
CAS: 302964-08-5 F: C16H13Cl2N5OS W: 394.28
Dasatinib intermediate-1 is an intermediate in the synthesis of Dasatinib (HY-10181). Dasatinib Is a highly potent, ATP
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.